References
- Beech H., Fransella F. Research and Experiment in Stuttering. Pergamon Press, Oxford 1968
- Bradv J., Burns D. A, Kijruvilla K. The acute effect of haloperidol and apomorphine on the severity of stuttering. Biological Psychiatry 1978; 13: 255–264
- Dalton P. Approaches to the Treatment of Stuttering. Croom Helm, London 1983
- Hills M., Armitage P. The two period crossover clinical trial. British Journal of Clinical Pharamacology 1979; 8: 7–20
- Johnson W., Darley F., Spriestersbach D. Diagnostic Methods in Speech Pathology. Harper and Row, New York 1963
- Kent L. Use of tranquillisers in the treatment of stuttering: reserpine, chlorpromazine, meprobamate and atarax. Journal of Speech and Hearing Disorders 1963; 28: 289–294
- Lewis G. R. O., Morley K. D., Lewis B. M., Jones P. J. The treatment of hypertension with verapamil. New Zealand Medical Journal 1978; 87: 351–354
- Murray T., Kelly P., Campbell L., Stefanik K. Haloperidol in the treatment of stutterers. British Journal of Psychiatry 1977; 130: 370–433
- Quinn O., Peachey E. Haloperidol in the treatment of stutterers. British Journal of Psychiatry 1973; 123: 247–248
- Walton J. Diffuse exercise–induced muscle pain of undetermined cause relieved by verapamil. The Lancet 1981; i: 993
- Wells O., Malcolm M. Controlled trial of treatment of 36 stutterers. British Journal of Psychiatry 1971; 119: 603–604
- Zachariah G. Verapamil in the management of stammering. The Antiseptic 1980; 77: 87–88
- Zimmerman G., Hanley J. M. A cinefluorographic investigation of repeated fluent productions of stutterers in an adaptation procedure. Journal of Speech and Hearing Research 1983; 26: 35–42